Clinical Trial Update: Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases [Phase 4]

View source ↗

Summary

This Phase 4 trial provides long-term efficacy and safety data for zoledronic acid in patients with bone metastases. The results help characterize the drug's co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Bone Neoplasms | Phase 4 | Status: COMPLETED